SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193805-09-000379
Filing Date
2009-02-13
Accepted
2009-02-13 16:24:16
Documents
1
Group Members
DEERFIELD CAPITAL, L.P.DEERFIELD INTERNATIONAL LIMITEDDEERFIELD MANAGEMENT COMPANY, L.P.DEERFIELD PARTNERS, L.P.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO SCHEDULE 13G e605025_13ga-medicines.txt SC 13G/A 25858
  Complete submission text file 0001193805-09-000379.txt   27821
Mailing Address
Business Address 8 CAMPUS DRIVE PARSIPPANY NJ 07054 973-656-1616
MEDICINES CO /DE (Subject) CIK: 0001113481 (see all company filings)

IRS No.: 043324394 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-60201 | Film No.: 09603893
SIC: 2834 Pharmaceutical Preparations

Mailing Address 780 THIRD AVENUE 37TH FLOOR NEW YORK NY 10017
Business Address 212-551-1600
Flynn James E (Filed by) CIK: 0001352546 (see all company filings)

Type: SC 13G/A